Sep 27, 2024 | 2024, Events, Scientific
Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted radioligand therapeutics on October 20 (session 604), entitled “Development of Multivalent OncoFAP Derivatives for the Tumor-Targeted Delivery of Theranostic Radionuclides”. Dr. Sebastian Oehler...Jul 16, 2024 | 2024, Events, Past Events, Scientific
Dr. Samuele Cazzamalli is giving a presentation entitled “DNA-Encoded Chemical Libraries for the Discovery of Highly Potent Tumor-Targeting Ligands and for the Development of Anti-Cancer Small Molecule Therapeutics”. Follow the link for more...Jul 16, 2024 | 2024, Events, Scientific
Prof. Dr. Dario Neri, Philogen’s CEO and CSO, is giving a lecture entitled “Antibody-Cytokine Fusion Proteins for Cancer Therapy: Late-Stage Clinical Results” Dr. Samuele Cazzamalli, Philogen Head of Small Molecule Therapeutics is giving a presentation...Jul 9, 2024 | 2024, Events, Investors, Past Events
Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024. Please contact us at IR@philogen.com or follow the link register to the event.
Recent Comments